Software Healthcare Sector

Azitra

Market Cap: US$9.1m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.

FibroBiologics

Market Cap: US$9.0m

A clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases.

Crigen Resources

Market Cap: AU$13.5m

Operates as a health and wellness company in Australia.

Comprehensive Healthcare Systems

Market Cap: CA$12.4m

Provides healthcare administrative software solutions in the United States.

Xenetic Biosciences

Market Cap: US$8.9m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Imunon

Market Cap: US$8.9m

A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States.

DATATRAK International

Market Cap: US$8.9m

A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

Check-Cap

Market Cap: US$8.9m

A clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps.

PreveCeutical Medical

Market Cap: CA$12.2m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Cambium Bio

Market Cap: AU$12.4m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

Soligenix

Market Cap: US$8.8m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

OSR Health

Market Cap: US$8.8m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.

Cizzle Biotechnology Holdings

Market Cap: UK£6.4m

Operates as a cancer diagnostics company in the United Kingdom.

CNS Pharmaceuticals

Market Cap: US$8.7m

A clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States.

Immuron

Market Cap: AU$12.1m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Exousia Bio

Market Cap: US$8.7m

A biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells.

Traws Pharma

Market Cap: US$8.6m

A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.

Rise Nano Optics

Market Cap: CA$11.9m

Develops nanotechnology-based eyewear solutions for eye protection and vision health.

CRISM Therapeutics

Market Cap: UK£6.2m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs in the British Virgin Islands.

Trinity Biotech

Market Cap: US$8.4m

Develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe.

Ernexa Therapeutics

Market Cap: US$8.2m

A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease.

HealthLynked

Market Cap: US$8.1m

A healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States.

AdAlta

Market Cap: AU$11.2m

A clinical-stage biotechnology company, develops cellular immunotherapies for the treatment of solid cancers in Australia.

Zenith Capital

Market Cap: US$8.0m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.

Creative Medical Technology Holdings

Market Cap: US$8.0m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

OptiBiotix Health

Market Cap: UK£5.8m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

Revive Therapeutics

Market Cap: CA$10.9m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Unidoc Health

Market Cap: CA$10.8m

Provides eHealth solutions in Canada.

Univec

Market Cap: US$7.8m

Provides health care services in the United States.

IceCure Medical

Market Cap: US$7.8m

A commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.

AIM ImmunoTech

Market Cap: US$7.7m

An immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Aclarion

Market Cap: US$7.7m

Operates as a healthcare technology company in the United States.

Co-Diagnostics

Market Cap: US$7.6m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Proteome Sciences

Market Cap: UK£5.6m

Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.

Intelligent Bio Solutions

Market Cap: US$7.6m

A medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.

Exicure

Market Cap: US$7.5m

Does not have significant operations.